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Late referral and modality choice in end-stage renal disease. prior to onset of renal replacement therapy (RRT). [1]
Background. We sought to determine whether late versus It has been demonstrated that patients who were re-
early referral to a nephrologist in patients with chronic kidney ferred to a nephrologist late received inferior treatmentdisease influences the initial choice of hemodialysis (HD) ver-
of renal anemia prior to initiation of RRT [2–4]. Suchsus peritoneal dialysis (PD) or the likelihood of switching treat-
patients were also less likely to have adequate vascularment modalities in the first six months of therapy.
Methods. Using New Jersey Medicare/Medicaid claims, all access once they started RRT, and as a consequence,
patients who started RRT between January 1991 and June 1996 they received their first dialysis via temporary vascular
and were diagnosed with renal disease more than one year access, associated with excess morbidity and cost [2–10].prior to RRT were identified. In the resulting cohort of 3014
Furthermore, it has been shown that LR was associatedpatients, 35% had their first nephrologist consultation 90
with higher mortality, morbidity, and health care costdays prior to initiation of dialysis.
Results. After controlling for demographic characteristics, once RRT was started [2, 3, 6, 8, 11–14].
socioeconomic status and underlying renal disease, age, black It has been speculated that LR might influence initial
race [Odds ratio (OR)  0.56], race other than black or white
treatment modality choice for RRT [5, 8, 9, 14]. How-(OR 0.56), and socioeconomic status (OR 0.68) influenced
ever, few studies have specifically addressed this issue,the choice of initial treatment modality, but timing of the refer-
ral did not. However, patients starting on PD who were referred and results are conflicting. Some researchers have found
late were 50% more likely to switch to HD than were patients that LR increases the likelihood of switching treatment
who saw a nephrologist earlier [Hazard’s ratio (HR)  1.47]. modality in the first few months of RRT [5, 14]. SuchIn patients originally on HD, diabetic nephropathy (HR 
switching is either a result of uninformed or urgent1.49) and black race (HR  0.69) influenced the likelihood of
choice before onset of RRT or an expression of inade-switching to PD, but the timing of referral did not.
Conclusions. These results refute earlier findings that late quate preparation for the modality that was chosen pri-
referral may limit access to PD. We found that modality choice marily. The latter might be due to complications that
depends on factors such as age, race, or socioeconomic status, arose as a function of rushed and suboptimal patientrather than on than timing of nephrologist referral. Late refer-
preparation. LR seems an intuitive candidate for beingral does not influence the likelihood to switch modality in
associated with both of these attributes.patients starting on HD, but does so in patients starting on PD.
Using a larger longitudinal data set than has been
previously available, we sought to address the question
Late nephrologist referral (LR) of patients with chronic whether timeliness of nephrologist referral influences the
kidney disease (CKD) is a public health problem of con- choice of RRT modality between HD and PD or the
siderable importance. According to the USRDS Dialysis likelihood of switching modality in the first six months
Morbidity and Mortality Study (Wave 2), 61% of hemo- of RRT. We also sought to measure whether the pre-
dialysis (HD) patients and 73% of peritoneal dialysis (PD) dictors of switching between therapies would be different
patients were first seen by a nephrologist 3 months in the first month of RRT compared with later months.
Key words: peritoneal dialysis, health services accessibility, renal replace- METHODS
ment therapy, kidney failure, physician’s practice patterns, nephrolo-
Patientsgist referral.
All patients who began RRT during the period 1990Received for publication February 13, 2001
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Table 1. Characteristics of study population (N3014)of dialysis were identified. These patients were identified
using the International Classification of Disease (9th re- Variable N %
vision, ICD-9) and the Physicians’ Current Procedural Age
45 83 2.8Terminology (CPT) codes for HD, PD, other dialysis,
45–54 137 4.6or renal transplantation. The first record of RRT during
55–64 261 8.7
this period was referred to as the index claim. To ensure 65–74 1288 42.7
75–84 1063 35.3eligibility in the Medicare, Pharmaceutical Assistance to
85 182 6.0the Aged and Disabled (PAAD), or Medicaid programs,
Gender
patients were required to have had at least one health Female 1320 43.8
Male 1694 56.2service encounter of any kind in each of the two years
Raceprior to their first maintenance dialysis procedure.
White 2240 74.3
Another requirement was that the first diagnosis of Black 586 19.4
Other 188 6.2renal insufficiency have occurred more than one year
Entitlement program/SESprior to the initiation of dialysis in order to exclude
Non-PAAD, non-Medicaid 2010 66.7
patients with new-onset renal disease, particularly those PAAD or Medicaid 1004 33.3
Renal diagnosesawith irreversible acute renal failure who may not have
Chronic renal failure with acute-onset 105 3.5had the opportunity for many encounters with a nephrol-
Polycystic kidney disease 157 5.2
ogist prior to dialysis. To be sure that RRT was chronic Diabetic nephropathy 875 29.0
Hypertensive nephropathy (malignant) 188 6.2in nature, patients were included only if they had at least
Hypertensive nephropathy (benign) 1851 61.4one month of RRT following the index procedure and
Pyelonephritis 118 3.9
regular use of dialysis without gaps of more than 63 days Obstructive nephropathy 171 5.7
Renovascular disease 131 4.4in their billing, unless renal transplantation occurred. A
Miscellaneous 1355 45.0smaller number of patients were excluded whose health
Unknown 86 2.9
care providers could not be identified. All patient identi- Timing of first nephrologist visit
90 days before dialysis 1039 34.5fiers were transformed into anonymous untraceable
90 days before dialysis 1975 65.5study numbers to protect confidentiality.
Initial modality of RRT
Hemodialysis 2344 77.8
Covariates Peritoneal dialysis 670 22.2
Each patient was characterized according to the fol- a Not mutually exclusive
lowing demographic variables in the twelve months prior
to initiation of dialysis: age, gender, race, socioeconomic
status (as reflected in whether the patient had been en-
their first encounter with a nephrologist was 90 daysrolled in the New Jersey Medicaid or the PAAD program
prior to onset of RRT.during this period), and the frequency and timing of
All PD patients were identified by the presence of avisits with a nephrologist. Patients enrolled in Medicaid are
procedure code for PD on the index date or by the place-under or near poverty level; patients receiving PAAD
ment of a PD catheter in those whose procedure codequalify by having an annual income of less than $18,587
was listed as “other dialysis.” Similarly, all HD patients(U.S. dollars) if single or $22,791 (U.S. dollars) if mar-
were identified by the presence of a HD procedure coderied. Therefore, a person who was not a member of any
or the absence of a specific code for a PD catheter amongof the two aforementioned programs was highly likely
those with “other dialysis” as their index claim code.to have an annual income greater than those limits. Phy-
Switching events were defined by the earliest claim forsician specialty was identified by Medicare and Medicaid
HD among those who had initiated RRT on PD and byspecialty codes as well as by Unique Physician Identifica-
the presence of the first claim for PD among those whotion Numbers (UPINs) that are assigned to all practicing
had started on HD. The time between index date andphysicians. For each physician encounter, provider num-
switching was recorded.bers were searched for the specialty code for nephrologists.
Information on all hospitalizations, physician visits, pro-
Statistical analysescedures, and nursing home care received by these pa-
A logistic regression model was built using initial mo-tients during this period was extracted. This made it
dality (HD vs. PD) as the outcome of interest forcingpossible to identify all diagnoses assigned to these pa-
candidates for predictors and likely confounders intotients by all clinicians who cared for them, including
the model. These included age (categorical), race (white,specific renal diagnoses, as well as comorbid conditions
black, other), gender, socioeconomic status (Medicaidsuch as hypertension, diabetes mellitus, congestive heart
or PAAD membership), and renal diagnoses (categori-failure, ischemic heart disease, and other relevant condi-
tions. Patients were defined as having a late referral if cal, see Table 1 for enumeration). Then all covariates
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Table 2. Factors associated with peritoneal dialysis (PD) versus hemodialysis (HD) as initial modality (full model)
Odds 95% Confidence
Variable ratio intervals P value
Age
45 1.60 0.96–2.65 0.069
45–54 1.53 1.01–2.31 0.043
55–64 0.74 0.52–1.05 0.093
65–74 1.00 Referent
75–84 0.89 0.73–1.08 0.242
85 0.72 0.48–1.09 0.121
Gender
Female 1.00 Referent
Male 0.96 0.80–1.14 0.612
Race
White 1.00 Referent
Black 0.56 0.43–0.72 0.001
Other 0.56 0.38–0.85 0.006
Entitlement program/SES
Non-PAAD, non-Medicaid 1.00 Referent
PAAD or Medicaid 0.68 0.56–0.83 0.001
Renal diagnosesa
Chronic renal failure non-specified 1.00 Referent
Chronic renal failure with acute-onset 0.70 0.42–1.18 0.178
Polycystic kidney disease 1.17 0.79–1.72 0.436
Diabetic nephropathy 1.11 0.91–1.36 0.316
Hypertensive nephropathy (malignant) 0.91 0.63–1.32 0.609
Hypertensive nephropathy (benign) 0.97 0.81–1.18 0.781
Pyelonephritis 1.28 0.83–1.96 0.271
Obstructive nephropathy 0.69 0.45–1.05 0.085
Renovascular disease 1.04 0.68–1.58 0.863
Miscellaneous 0.88 0.73–1.06 0.176
Unknown 1.12 0.67–1.86 0.673
Timing of nephrologist referral
Early referral (90 days before RRT) 1.00 Referent
Late referral (90 days before RRT) 0.92 0.76–1.11 0.383
a Not mutually exclusive
were tested for independent significance at P  0.01. 5242 patients had their first renal diagnosis at least one
year prior to the initiation of dialysis. Six hundredWe then sought to evaluate determinants of time to first
modality switch. Individual predictors were evaluated twenty-six patients in this group had less than 30 days
of renal replacement therapy (RRT), indicating that theyvisually using Kaplan-Meier plots and quantitatively
with Cox proportional hazards regression models. Pa- had acute renal failure. Five hundred ninety-nine patients
had more than 63 days without claims for RRT and sur-tients were censored at death or when they received a
renal transplant. We tested for violations of the propor- vived without additional dialysis care, and 1002 lacked
adequate data describing their health care providers.tional hazard assumption by introducing interaction terms
with time for each covariate. Finally, we modeled time This left a study population of 3014 patients (Table 1).
Among these 3014 incident RRT patients, 1975 (65.5%)to first modality switch with Cox proportional hazards
models and introduced the same covariates as mentioned were referred to a nephrologist earlier than 90 days prior
to initiation of chronic RRT.previously in this article, with covariates considered sig-
nificant at P 0.01. All statistical analyses used the SAS
Determinants of modality choicesystem for Unix, version 6.11 (SAS Institute, Inc., Cary,
NC, USA). Among the 3014 incident RRT patients, 2344 started
on HD, and 670 began RRT on PD. In the univariate
analyses, the pre-Medicare age group was more likely
RESULTS
to begin with PD rather than HD (55 to 64 years com-
Population and patient characteristics pared with 65 to 74 years, P  0.026). Black race (P 
0.0001), nonwhite/nonblack race (P  0.050), and lowerA total of 17,884 patients were identified who under-
went RRT at some point during the years 1991 to mid- socioeconomic status (P  0.0001) were all significantly
predictive of HD rather than PD as first modality choice.1996. Of these patients, 12,557 had adequate baseline
data for a full year prior to dialysis in Medicaid and/or In the full logistic regression model, black race, race
other than white or black, and socioeconomic status wereMedicare to permit further study. In this population,
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Fig. 1. Modality switch by original modality
and timing of referral. Symbols are: (thick
black line) early referral and treatment begun
on hemodialysis (HD); (thin black line) late
referral and treatment begun on HD; (thick
grey line) early referral and treatment begun
on peritoneal dialysis (PD); (thin grey line)
late referral and treatment begun on PD.
strong independent predictors of modality choice after first six months of RRT [HR  1.489, 95% CI (1.132,
1.960); Table 3]. Patients in the age group of 75 to 84controlling for age, gender, underlying renal disease and
timing of nephrologist referral (Table 2). Black patients year olds were 30% less likely to switch from HD to PD
and patients of nonwhite, nonblack race were each 44% compared with the referent group of 65- to 74-year-old
less likely to start RRT on PD than were white patients patients [HR  0.734, 95% CI (0.544, 0.991)], as were
[ORblack race  0.558, 95% CI (0.432, 0.720); ORother race  black patients [HR 0.686, 95% CI (0.487, 0.966)]. Late
0.564, 95% CI (0.376, 0.846)]. Patients of lower socioeco- nephrologist referral was unassociated with modality
nomic status as reflected in Medicaid and/or PAAD en- switch among HD patients in both the crude (P 0.401)
rollment were 32% less likely to start RRT on PD [OR and the fully adjusted analysis (P  0.619). However,
0.681, 95% CI (0.558, 0.832)]. There was a trend for among patients starting RRT on PD, in the full regression
patients between 45 and 54 years of age (OR  1.530; model LR was significantly associated with the likelihood
P  0.043) and for patients less than 45 years (OR  of switching modality (Table 4): Patients who were re-
1.598, P  0.069) to be more likely to initiate RRT on ferred to a nephrologist late were 50% more likely to
PD. However, LR did not predict the initial dialysis switch from PD to HD than were patients who saw a
modality choice after controlling for these confounders nephrologist more than three months prior to onset of
(P  0.383). RRT [HR 1.47, 95% CI (1.121, 1.927)]. All other covari-
ates in the fully adjusted model remained nonsignificant.
Determinants of modality switch The final step of our analysis investigated whether
When plotting the cumulative probability of switching predictors of modality switch in the first month of RRT
modality versus time after start of RRT for the four joint also were predictive in months 2 to 6 of RRT. Among
strata of incident modality and referral status, it became incident HD patients, diabetic nephropathy was a strong
evident that the proportional hazards assumption would predictor of switching to PD in months 2 to 6 of dialysis
not hold (Fig. 1). When comparing the probability of (P  0.011), but not so in the first month of treatment
having switched at three months, patients starting RRT (P  0.102). Among incident PD patients, LR was
on HD were dramatically less likely to switch modality strongly predictive of patients switching to HD within
than were those initially on PD (11.9 vs. 41.7%; P  the first month of RRT (P  0.005) but not afterward
0.001). Furthermore, LR seemed to affect the likelihood (P  0.513).
of switching modality in the PD cohort uniquely, while
the Kaplan-Meier curves of late versus early referral
DISCUSSIONpatients beginning with HD were virtually identical.
This is the largest analysis to date of patient-specificTherefore, we proceeded with analyses stratified by type
and physician-specific characteristics predicting the se-of initial modality.
lection of initial dialysis modality. Our observation thatIn the full proportional hazards model that included
late referral to nephrologists is not associated with mod-all covariates, HD patients with diabetic nephropathy
were 50% more likely to switch from HD to PD in the ality choice when controlling for several important con-
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Table 3. Factors associated with switching to peritoneal dialysis (PD) among incident hemodialysis (HD) patients (full model)
Hazards 95% Confidence
Variable ratio intervals P value
Age
45 0.74 0.30–1.83 0.508
45–54 1.14 0.62–2.11 0.674
55–64 1.00 0.66–1.54 0.989
65–74 1.00 Referent
75–84 0.73 0.54–0.99 0.043
85 0.85 0.46–1.55 0.597
Gender
Female 1.00 Referent
Male 0.89 0.69–1.15 0.361
Race
White 1.00 Referent
Black 0.69 0.49–0.97 0.031
Other 1.00 0.60–1.66 0.989
Entitlement program/SES
Non-PAAD, non-Medicaid 1.00 Referent
PAAD or Medicaid 0.92 0.70–1.21 0.541
Renal diagnosesa
Chronic renal failure non-specified 1.00 Referent
Chronic renal failure with acute-onset 0.96 0.49–1.88 0.908
Polycystic kidney disease 0.72 0.37–1.41 0.344
Diabetic nephropathy 1.49 1.13–1.96 0.004
Hypertensive nephropathy (malignant) 1.05 0.64–1.73 0.842
Hypertensive nephropathy (benign) 1.02 0.77–1.36 0.872
Pyelonephritis 1.18 0.64–2.16 0.602
Obstructive nephropathy 1.12 0.66–1.90 0.683
Renovascular disease 0.86 0.44–1.68 0.656
Miscellaneous 1.02 0.79–1.33 0.860
Unknown 1.01 0.44–2.35 0.977
Timing of nephrologist referral
Early referral (90 days before RRT) 1.00 Referent
Late referral (90 days before RRT) 0.93 0.71–1.23 0.619
a Not mutually exclusive
founders is in contrast with previous findings [5, 8, 9, guishes the present population under study from previ-
ous ones, where a number of patients had not had any14]. Radcliffe, Phillips and Oliver reported that among
all incident patients, 22% of ER and 61% of LR patients medical care prior to initiation of renal replacement ther-
apy [7]. Thus, these findings expand on previous studieswere treated with PD at the Oxford renal unit in 1981
[5]. While in Radcliffe et al’s study LR seemed to be by demonstrating that that the putative association be-
tween LR and modality choice is more complicated thanassociated with a higher likelihood of starting RRT on
PD, the opposite was found by Sesso and Belasco [8], originally anticipated. Patients referred to a nephrologist
late who initiated PD were most likely to switch to HD,Levin et al (nonsignificant) [9], and Schmidt et al [14].
However, none of these studies controlled for potential whereas the converse relationship was not observed.
As a byproduct of our primary research question, weconfounders. The relatively large cohort of incident
ESRD patients studied in the present analysis offers also were able to identify other factors that were associ-
ated with modality choice. While younger age was anconsiderably more power to detect any effects if they
are in fact present. Moreover, important drivers of mod- intuitive factor to favor PD, black race, race other than
black or white, and lower socioeconomic status wereality choice on a macro (cross-national) level—financial
incentives and reimbursement—can be assumed to be each very strongly associated with starting RRT on HD
rather than PD. These findings confirm earlier studiesconstant in our study setting [15]. However, local deter-
minants such as community-based standards and the ex- that have found younger age and white race to be associ-
ated with greater use of PD when assessed at day 60 ofperience and preferences of local opinion leaders cannot
be captured and controlled. By requiring patients in this RRT [1]. It is not known, however, whether the racial
differences in the use of PD are due to health care accesscohort to have been diagnosed with renal disease at least
one year prior to onset of RRT, patients were known issues or due to different preferences. Furthermore, so-
cial and cultural differences have been shown to be pre-to have had at least some level of contact with healthcare
providers, who would have had the chance to refer the dictors of modality choice. [15]
The question of whether LR had an impact on thepatient to a nephrologist in a timely fashion. This distin-
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Table 4. Factors associated with switching to hemodialysis (HD) among incident peritoneal dialysis (PD) patients (full model)
95% Confidence
Variable HR intervals P value
Age
45 0.47 0.21–1.03 0.059
45–54 0.87 0.49–1.55 0.638
55–64 0.70 0.40–1.20 0.196
65–74 1.00 Referent
75–84 0.81 0.60–1.09 0.167
85 0.95 0.51–1.78 0.865
Gender
Female 1.00 Referent
Male 1.10 0.84–1.43 0.502
Race
White 1.00 Referent
Black 1.22 0.85–1.76 0.279
Other 0.68 0.34–1.37 0.278
Entitlement program/SES
Non-PAAD, non-Medicaid 1.00 Referent
PAAD or Medicaid 0.96 0.71–1.31 0.803
Renal diagnosesa
Chronic renal failure non-specified 1.00 Referent
Chronic renal failure with acute-onset 0.96 0.39–2.35 0.927
Polycystic kidney disease 0.53 0.27–1.04 0.066
Diabetic nephropathy 1.05 0.79–1.40 0.740
Hypertensive nephropathy (malignant) 0.96 0.57–1.64 0.887
Hypertensive nephropathy (benign) 1.16 0.87–1.53 0.313
Pyelonephritis 1.65 0.94–2.88 0.079
Obstructive nephropathy 0.96 0.50–1.83 0.893
Renovascular disease 0.49 0.22–1.11 0.089
Miscellaneous 0.96 0.73–1.25 0.737
Unknown 1.46 0.75–2.86 0.269
Timing of nephrologist referral
Early referral (90 days before RRT) 1.00 Referent
Late referral (90 days before RRT) 1.47 1.12–1.93 0.005
a Not mutually exclusive
likelihood to switch therapy after start of RRT has pre- istic that strongly predicted switching from HD to PD,
with these patients being 50% more likely to switch thanviously been reported only in a small cohort of 238 new
dialysis patients. Schmidt reported that more LR than these with unspecified chronic renal failure (HR  1.49,
95% CI, 1.13 to 1.96). This effect was weak in the firstER patients had switched (P  0.08), and most of these
switches were from HD to PD [14]. However, probably month after onset of RRT (HR  1.32, P  0.102), but
strong after the first month (HR 1.88, P 0.011). Thisbecause of the small sample size, these results were unad-
justed for potential confounders. Furthermore, the event higher likelihood of HD patients with diabetic nephropa-
thy to switch to PD might be an expression of the greaterof interest was evaluated using a cross-sectional compari-
son of modalities at onset of RRT and four months later. incidence of access complications, hemodynamic insta-
bility or poor quality of HD over time in this groupThis analytical approach ignores all those patients who
switched back to their original modality. [16–18]. Black race was associated with a lower likeli-
hood of switching from HD to PD (HR  0.69, P Patients who started RRT on PD were more likely to
switch to HD than vice versa. Moreover, LR was strongly 0.031), an effect that was not present in the first month
of RRT.associated with switching modality in patients who
started RRT on PD, but not in those originally on HD. Late referral was the only strong predictor of switching
in the opposite direction from PD to HD. Patients re-We chose to evaluate time to first modality switch, rather
than differences in modality choice between two points ferred late who started RRT on PD were nearly 50%
more likely to switch to HD (HR  1.47, 95% CI, 1.12in time, using switching modality as an indicator of inade-
quate preparation for chronic RRT. Whether a change to 1.93). This effect was very pronounced in the first
month of RRT (HR  1.57, P  0.005), while it was notin modality was a consequence of medical complications
or an adjustment to comply with a patient’s preferences present in the following months of RRT (HR  1.20,
P 0.513). This finding suggests that some patients mayis beyond the scope of this analysis and irrelevant for
the specific question posed. acclimate to PD as their treatment modality.
While observational research using claims databasesDiabetic nephropathy was the only patient character-
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is a powerful tool for studying healthcare utilization in United States and the New Jersey patient cohort, it sug-
gests that local factors other than the timing of referrallarge numbers of typical patients, this approach has im-
portant limitations that must be considered. The patient may have a strong influence on modality choice. Like
most observational analyses, the findings herein are in-inclusion algorithm first identifies patients with ESRD
and then data are collected from their pre-ESRD phase. tended to be hypothesis generating.
In summary, we have found that LR is not associatedThe survival bias that is introduced by this strategy is
not a substantial confounder, since our study examines with initial RRT modality choice after adjusting for de-
mographic and clinical characteristics, and LR does notmodality choice for RRT, not the decision to pursue RRT.
Moreover, our dataset contains comprehensive informa- influence the probability of switching therapy once HD
is chosen. The former contradicts recent studies demon-tion on all patients in the cohort for at least one year
prior to onset of RRT. One strength of this approach is strating that patients are less likely to start RRT on
PD when referred late [14]. However, LR patients whothat it minimizes classification bias. The dichotomized
outcome variable “late referral” is based solely on the started RRT on PD were more likely to switch to HD
timing of the first nephrologist contact. Since there were than those referred early. Perhaps because they did not
no nephrologist visits between 90 and 365 days prior to have appropriate vascular access for HD, some patients
RRT, the only way a patient could falsely be classified may have started RRT on PD to bridge the period until
a “late referral” is by having had a nephrologist visit their fistula or graft was ready to use. This may explain
before he or she had been enrolled in Medicare/Medic- the discrepancy between our findings and earlier studies
aid, which per definition of our population would have that assessed modality choice a fixed period of time after
been 365 days prior to RRT. While this is possible, it onset of RRT, under the premise that it takes awhile un-
is unlikely that an earlier nephrologist visit (365 days til patients find the modality that suits their needs best.
before RRT) would occur, but not trigger a follow-up However, by ignoring the first few weeks and months, im-
visit at an interval smaller than nine months. Moreover, portant events that affect patients may not be fully cap-
when the models were re-evaluated using a cutoff at 160 tured. LR can impair educated choices and the adequate
days, the results were nearly identical. Missing claims or preparation for PD and thus may make an important
diagnosis codes may lead to an underestimation of co- contribution to the excess morbidity, mortality and cost
morbid conditions. Undercounting of some nephrologist that has been observed for patients with chronic renal
visits is possible, but unlikely. When present, there is no insufficiency who are first seen by a nephrologist late in
a priori reason that it should occur in a nonrandom man- the course of their disease. Therefore, early referral may
ner, and thus, misclassification would be equally distrib- improve technique survival for ESRD patients, which will
uted and dilute apparent effects rather than exaggerate reduce the societal costs by minimizing or delaying the
them. Moreover, it is possible that we were unable to costs associated with switching techniques (PD→HD), as
capture important confounders, and this is the reason well as reflecting the reduced costs of PD versus HD.
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